#United States #New York #Levi & Korsinsky #BYAH #Park Ha Bio

Investors Alert: Potential Class Action Against Park Ha Biological Technology Co.

The investment landscape is often fraught with risks, exemplified recently by Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH), which has drawn significant attention following a dramatic stock upheaval since its inception. Investors are urged to review their options, particularly in light of a class action lawsuit currently being pursued by Levi & Korsinsky, LLP. The complaint highlights significant losses suffered by shareholders, especially those who Brought shares between late December 2024 and early July 2025.

The Rise and Fall of BYAH Shares

Park Ha made its initial public offering on December 27, 2024, offering 1,200,000 shares at $4.00 each, netting an estimated $4.8 million. Initially, the stock showed promise, climbing to an impressive $41.49 in just six months. However, this meteoric rise turned catastrophic, crashing by 93% in a single day to close at $2.99 on July 8, 2025. Over $1 billion in market value vanished without any corporate announcement or explanation.

The timeline of events is critical. After opening on the Nasdaq Capital Market on December 30, 2024, share activity remained quiet until a surge beginning on June 18, 2025. On July 7, the stock reached its peak, yet the next day’s crash shocked investors and left many wondering what went awry. The absence of any official commentary from Park Ha during this tumultuous period is at the heart of the lawsuit.

Allegations of Promotional Manipulation

Central to the allegations is the claim of undisclosed promotional activities that may have artificially inflated share prices. The securities action contends that there was a carefully orchestrated effort to boost the stock’s market value, unbeknownst to the public investors. The escalation in share price appeared disconnected from Park Ha’s core business operations, particularly as no corresponding announcements were ever made regarding new products or initiatives.

On July 10, just two days after the collapse, Park Ha registered an additional 4,500,000 shares under an amended incentive plan, a move that further raised concerns among shareholders about the company's transparency and direction.

Class Action Participation Details

Shareholders looking to recover losses from this steep decline are encouraged to act swiftly. Individuals who acquired BYAH shares during the class period (December 27, 2024, to July 8, 2025) might be eligible for compensation. The cutoff date to file for lead plaintiff status is September 28, 2026.

Key Points for Investors:

• - Investors may be eligible for recovery, even if shares were sold at a loss.
• - A lead plaintiff plays a crucial role, often representing the interests of all shareholders involved, appointed based on documented losses.
• - There are no upfront costs involved for participating in the class action, as legal fees will be contingent upon recovery from the lawsuit.

Frequently Asked Questions

• - When did misleading actions occur? The timeline indicates troubling actions from December 2024 through July 2025, coinciding with the IPO and subsequent events.
• - What action is required to join? Interested parties should gather brokerage statements proving share purchases during the class period, as these will be necessary to demonstrate loss.

The repercussions from Park Ha Biological Technology Co.’s dramatic stock activity serve as a stark warning to investors about the nuances of market participation and the potential hazards of undisclosed promotional activities. With legal actions underway, many are eager for a clearer picture of how these complex events could unfold.

For those seeking more information about the lawsuit specifics or interested in potentially participating, direct contact with the Levi & Korsinsky firm is highly advised. Contact attorney Joseph E. Levi at (212) 363-7500 or via email at [email protected]

As the situation evolves, keeping to date with developments will be essential for affected investors. Transparency and accountability remain key in navigating the aftermath of such market events.